Literature DB >> 18546180

Investigation of the antiadhesive properties of human mesothelial cells cultured in vitro on implantable surgical materials.

Stacy-Paul Wilshaw1, Dermot Burke, John Fisher, Eileen Ingham.   

Abstract

The aim of the study was to evaluate the interactions of Permacol, Prolene mesh, Surgisis Gold, and Alloderm with human mesothelial cells in vitro. The capacity of primary human mesothelial cells to adhere to the surface of Alloderm, Surgisis Gold, Prolene mesh, and Permacol as well as support the proliferation and viability of the seeded cells was determined. Production of antifibrinolytic, fibrinolytic, and inflammatory mediators (IL-8, TPA, MMP-1, PAI-1, and TGF-beta) was assessed over an 8-day period. The adhesive nature of the implantable materials was determined by assessment of the strength of any fibrin clots formed between two surfaces of each implant material. Surgisis Gold and Permacol were capable of supporting the attachment and proliferation of primary human mesothelial cells and maintaining viability over an 8-day culture period. Mesothelial cells were shown to have covered the surface of Permacol and Surgisis Gold in a monolayer. The viability of cells cultured on Permacol was significantly greater than the other implant materials tested. Mesothelial cells cultured on Permacol or Surgisis were shown to be producing high levels of fibrinolytic compounds and low levels of antifibrinolytic and inflammatory mediators. Alloderm was shown to produce high levels of IL-8 and antifibrinolytic mediators when compared with the other implantable materials. Permacol was shown to be an unreliable surface for clot formation in vitro and any clots formed were shown to be significantly weaker than the clots produced between two surfaces of tissue culture plastic, Prolene mesh, Alloderm, and Surgisis Gold. This in vitro study indicated that Permacol and Surgisis Gold supported the growth and fibrinolytic activity of human mesothelial cells; however, Permacol was shown to be superior in this respect. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18546180     DOI: 10.1002/jbm.b.31148

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  6 in total

Review 1.  Current strategies and future perspectives for intraperitoneal adhesion prevention.

Authors:  Christoph Brochhausen; Volker H Schmitt; Constanze N E Planck; Taufiek K Rajab; David Hollemann; Christine Tapprich; Bernhard Krämer; Christian Wallwiener; Helmut Hierlemann; Rolf Zehbe; Heinrich Planck; C James Kirkpatrick
Journal:  J Gastrointest Surg       Date:  2012-06       Impact factor: 3.452

2.  Letter. Re: Orenstein et al. (2010) Activation of human mononuclear cells by porcine biologic meshes in vitro. Hernia 14(4):401-407.

Authors:  N J Smart; D Khan; I R Daniels
Journal:  Hernia       Date:  2010-10-16       Impact factor: 4.739

3.  Porcine dermal collagen (Permacol) for chest and abdominal wall reconstruction in thoraco-omphalopagus conjoined twin separation.

Authors:  Jonathan Saul Karpelowsky; Alastair J W Millar
Journal:  Pediatr Surg Int       Date:  2009-10-10       Impact factor: 1.827

4.  Rejection of Permacol mesh used in abdominal wall repair: a case report.

Authors:  Franchesca T Wotton; Jacob A Akoh
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

5.  Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature.

Authors:  Federico Coccolini; Fausto Catena; Valentina R Bertuzzo; Giorgio Ercolani; Antonio Pinna; Luca Ansaloni
Journal:  Updates Surg       Date:  2013-05-01

6.  Instant Abdominal Wall Reconstruction with Biologic Mesh following Resection of Locally Advanced Colonic Cancer.

Authors:  Oskay Kaya; Engin Olcucuoglu; Gaye Seker; Hakan Kulacoglu
Journal:  Case Rep Med       Date:  2012-04-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.